Analytical Data
-
Gene name
SSTR1
- Application
-
Alternative Names
SS-1-R;SS1-R;SS1R;SST1
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
p30872
-
Expression Region
1-391 aa
-
AA Sequence
MFPNGTASSPSSSPSPSPGSCGEGGGSRGPGAGAADGMEEPGRNASQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCTSRITTL
-
Molecular Weight
44.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SSTR1, or somatostatin receptor type 1, is a G-protein coupled receptor that plays a crucial role in a variety of physiological processes by mediating the effects of somatostatin, a neuropeptide involved in the inhibition of hormone secretion and neurotransmission. Research into SSTR1 has gained significant attention due to its implications in several pathological conditions, including neuroendocrine tumors, where its expression can influence tumor growth and proliferation. The development of SSTR1 recombinant proteins facilitates the exploration of receptor structure and function, enabling researchers to investigate signaling pathways and the receptor's role in various biological contexts. Additionally, SSTR1 is a potential target for therapeutic interventions, particularly in the development of radioligand therapies for tumors that overexpress this receptor. The ability to produce recombinant SSTR1 also provides opportunities for high-throughput screening of potential drug candidates that could modulate receptor activity. As the understanding of SSTR1 and its mechanisms evolves, it holds promise for advancing both basic scientific knowledge and clinical applications, particularly in the fields of oncology and endocrinology. Hence, the study of SSTR1 recombinant proteins is integral to unlocking new strategies for disease management and therapy optimization.
